Skip to main content

Advertisement

Log in

Inadequate levothyroxine replacement for primary hypothyroidism is associated with poor health-related quality of life–a Brazilian multicentre study

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

This study aimed to verify the impact of levothyroxine replacement on health-related quality of life (HRQoL) in a Brazilian sample of primary hypothyroidism patients. A cross-sectional study was performed with 2,057 consecutive primary hypothyroidism patients on levothyroxine (LT4) replacement at four referral centers in Brazil (median age = 53; 25th percentile = 43; 75th percentile = 61 years). Patient biochemical data were acquired from medical records, and patients completed a questionnaire on socioeconomic issues and clinical signs and symptoms of hypothyroidism. HRQoL was assessed using the SF-36v2. Patients were divided into three groups according to TSH levels: overtreated (OvT; TSH < 0.4 mU/L), appropriately treated (AT; TSH between 0.4 and 4.0 mU/L), and undertreated (UnT; TSH > 4.0 mU/L). Patients were also analyzed by TSH and FT4 serum levels: overt hyperthyroidism (OHyper; TSH < 0.4 mU/L and FT4 > 1.9 ng/dL), subclinical hyperthyroidism (SHyper; TSH < 0.4 mU/L and FT4 0.8–1.9 ng/dL), subclinical hypothyroidism (SHypo; TSH > 4.0 mU/L and FT4 0.8–1.9 ng/dL), and overt hypothyroidism (OHypo; TSH > 4.0 mU/L and FT4 < 0.8 ng/dL). A total of 14.4 % of patients were OvT, with 13.0 % SHyper and 1.4 % OHyper. The prevalence of UnT was 25.9 %, with 21.5 % SHypo and 4.4 % OHypo. Overtreatment was not associated with HRQoL impairment. UnT patients had worse HRQoL than AT patients, especially for physical and emotional aspects, independent of SHypo or OHypo status. Hypothyroidism undertreatment is associated with poor patient HRQoL. Therefore, adequate LT4 therapy should be given to maintain serum TSH within the reference range.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. J.P. Almandoz, H. Gharib, Hypothyroidism: etiology, diagnosis, and management. Med. Clin. North Am. 96, 203–221 (2012)

    Article  PubMed  CAS  Google Scholar 

  2. D. Khandelwal, N. Tandon, Overt and subclinical hypothyroidism: who to treat and how. Drugs 72, 17–33 (2012)

    Article  PubMed  CAS  Google Scholar 

  3. A.R. Cappola, P.W. Ladenson, Hypothyroidism and atherosclerosis. J. Clin. Endocrinol. Metab. 88, 2438–2444 (2003)

    Article  PubMed  CAS  Google Scholar 

  4. M.H. Samuels, K.G. Schuff, N.E. Carlson, P. Carello, J.S. Janowsky, Health status, psychological symptoms, mood, and cognition in L-thyroxine-treated hypothyroid subjects. Thyroid 17, 249–258 (2007)

    Article  PubMed  CAS  Google Scholar 

  5. P. Clausen, H. Mersebach, B. Nielsen, B. Feldt-Rasmussen, U. Feldt-Rasmussen, Hypothyroidism is associated with signs of endothelial dysfunction despite 1-year replacement therapy with levothyroxine. Clin. Endocrinol. (Oxf) 70, 932–937 (2009)

    Article  CAS  Google Scholar 

  6. H. Zulewski, B. Müller, P. Exer, A.R. Miserez, J.J. Staub, Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. J. Clin. Endocrinol. Metab. 82, 771–776 (1997)

    Article  PubMed  CAS  Google Scholar 

  7. A.T. Dugbartey, Neurocognitive aspects of hypothyroidism. Arch. Intern. Med. 158, 1413–1418 (1998)

    Article  PubMed  CAS  Google Scholar 

  8. D.S. Cooper, B. Biondi, Subclinical thyroid disease. Lancet 379, 1142–1154 (2012)

    Article  PubMed  Google Scholar 

  9. H.J. Baskin, R.H. Cobin, D.S. Duick, H. Gharib, R.B. Guttler, M.M. Kaplan et al., American Association of Clinical Endocrinologists American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr. Pract. 8, 457–469 (2002)

    PubMed  Google Scholar 

  10. C.R. Harington, G. Barger, Chemistry of thyroxine–constitution and synthesis of thyroxine. Biochem. J. 21, 169–183 (1927)

    PubMed  CAS  Google Scholar 

  11. O.E. Okosieme, G. Belludi, K. Spittle, R. Kadiyala, J. Richards, Adequacy of thyroid hormone replacement in a general population. QJM 104, 395–401 (2011)

    Article  PubMed  CAS  Google Scholar 

  12. G.J. Canaris, N.R. Manowitz, G. Mayor, E.C. Ridgway, The colorado thyroid disease prevalence study. Arch. Intern. Med. 160, 526–534 (2000)

    Article  PubMed  CAS  Google Scholar 

  13. P. Vigário, P. Teixeira, V. Reuters, C. Almeida, M. Maia, M. Silva et al., Perceived health status of women with overt and subclinical hypothyroidism. Med. Princ. Pract. 18, 317–322 (2009)

    Article  PubMed  Google Scholar 

  14. C. McMillan, C. Bradley, S. Razvi, J. Weaver, Evaluation of new measures of the impact of hypothyroidism on quality of life and symptoms: the ThyDQoL and ThySRQ. Value Health. 11, 285–294 (2008)

    Article  PubMed  Google Scholar 

  15. J.E. Ware Jr, SF-36 health survey update. Spine (Phila Pa 1976) 25, 3130–3139 (2000)

    Article  Google Scholar 

  16. L.L. Somwaru, A.M. Arnold, N. Joshi, L.P. Fried, A.R. Cappola, High frequency of and factors associated with thyroid hormone over-replacement and under-replacement in men and women aged 65 and over. J. Clin. Endocrinol. Metab. 94, 1342–1345 (2009)

    Article  PubMed  CAS  Google Scholar 

  17. R.M. Bagattoli, M. Vaisman, J.S. Lima, L.S. Ward, Estudo de adesão ao tratamento do hipotiroidismo. Arq. Bras. Endocrinol. Metab. 44, 483–487 (2000)

    Article  Google Scholar 

  18. J. John-Kalarickal, G. Pearlman, H.E. Carlson, New medications which decrease levothyroxine absorption. Thyroid 17, 763–765 (2007)

    Article  PubMed  CAS  Google Scholar 

  19. M. Centanni, Thyroxine treatment: absorption, malabsorption, and novel therapeutic approaches. Endocrine 43(1), 8–9 (2013)

    Article  PubMed  CAS  Google Scholar 

  20. R. Vita, G. Saraceno, F. Trimarchi, S. Benvenga, A novel formulation of L-thyroxine (L-T4) reduces the problem of L-T4 malabsorption by coffee observed with traditional tablet formulations. Endocrine 43(1), 154–160 (2013)

    Article  PubMed  CAS  Google Scholar 

  21. P.F. Teixeira, V.S. Reuters, M.M. Ferreira, C.P. Almeida, F.A. Reis, A. Buescu et al., Lipid profile in different degrees of hypothyroidism and effects of levothyroxine replacement in mild thyroid failure. Transl. Res. 151, 224–231 (2008)

    Article  CAS  Google Scholar 

  22. B. Demartini, A. Masu, S. Scarone, A.E. Pontiroli, O. Gambini, Prevalence of depression in patients affected by subclinical hypothyroidism. Panminerva Med. 52, 277–282 (2010)

    PubMed  CAS  Google Scholar 

  23. R. Sharma, T.K. Sharma, G.G. Kaushik, S. Sharma, S.K. Vardey, M. Sinha, Subclinical hypothyroidism and its association with cardiovascular risk factors. Clin. Lab. 57, 719–724 (2011)

    PubMed  CAS  Google Scholar 

  24. F.Y. Tseng, W.Y. Lin, C.C. Lin, L.T. Lee, T.C. Li, P.K. Sung et al., Subclinical hypothyroidism is associated with increased risk for all-cause and cardiovascular mortality in adults. J. Am. Coll. Cardiol. 60, 730–737 (2012)

    Article  PubMed  CAS  Google Scholar 

  25. B. Biondi, Natural history, diagnosis and management of subclinical thyroid dysfunction. Best. Pract. Res. Clin. Endocrinol. Metab. 26, 431–446 (2012)

    Article  PubMed  CAS  Google Scholar 

  26. S. Gulseren, L. Gulseren, Z. Hekimsoy, P. Cetinay, C. Ozen, B. Tokatlioglu, Depression, anxiety, health-related quality of life, and disability in patients with overt and subclinical thyroid dysfunction. Arch. Med. Res. 37, 133–139 (2006)

    Article  PubMed  Google Scholar 

  27. V.S. Reuters, A. Buescu, F.A. Reis, C.P. Almeida, P.F. Teixeira, A.J. Costa et al., Clinical and muscular evaluation in patients with subclinical hypothyroidism. Arq. Bras. Endocrinol. Metabol. 50, 523–531 (2006)

    Article  PubMed  Google Scholar 

  28. V.S. Reuters, C.P. Almeida, P.F. Teixeira, P.S. Vigário, M.M. Ferreira, C.L. Castro et al., Effects of subclinical hypothyroidism treatment on psychiatric symptoms, muscular complaints, and quality of life. Arq. Bras. Endocrinol. Metabol. 56, 128–136 (2012)

    PubMed  Google Scholar 

  29. G.P. Bianchi, V. Zaccheroni, E. Solaroli, F. Vescini, R. Cerutti, M. Zoli et al., Health-related quality of life in patients with thyroid disorders. Qual. Life Res. 13, 45–54 (2004)

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We would like to thank Merck Brazil for financial support.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Patrícia dos Santos Vigário.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vigário, P.d.S., Vaisman, F., Coeli, C.M. et al. Inadequate levothyroxine replacement for primary hypothyroidism is associated with poor health-related quality of life–a Brazilian multicentre study. Endocrine 44, 434–440 (2013). https://doi.org/10.1007/s12020-013-9886-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-013-9886-1

Keywords

Navigation